Det Norske Veritas Healthcare, Inc. – Trademark Portfolio
Entity Type: 03
Det Norske Veritas Healthcare, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NIAHO. The owner is based in Milford, OH.
400 Techne Center Drive, Suite 350
Milford, OH 45150
Showing of trademarks Trademarks
Trademark Classifications
Det Norske Veritas Healthcare, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Det Norske Veritas Healthcare, Inc. have?
Det Norske Veritas Healthcare, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 5 cancelled.
What trademark classes does Det Norske Veritas Healthcare, Inc. file in?
Det Norske Veritas Healthcare, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Det Norske Veritas Healthcare, Inc.'s most well-known trademarks?
Det Norske Veritas Healthcare, Inc.'s registered trademark portfolio includes well-known marks such as NIAHO. These are among 1 currently registered trademark in the portfolio.
What is Det Norske Veritas Healthcare, Inc.'s trademark registration success rate?
Det Norske Veritas Healthcare, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.